HAYDEN DONALD J JR 4
4 · Theseus Pharmaceuticals, Inc. · Filed May 18, 2022
Insider Transaction Report
Form 4
HAYDEN DONALD J JR
Director
Transactions
- Award
Stock Option (right to buy)
2022-05-17+60,000→ 60,000 totalExercise: $8.02Exp: 2032-05-17→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]The options are subject to a service-based vesting requirement, which shall be satisfied over a three-year period with 1/36th of the options vesting on June 17, 2022 and 1/36th of the options vesting monthly thereafter, subject to the Reporting Person's continuous service with the issuer on each such vesting date.